On Tap for This Week: Huntington Bancshares Incorporated (HBAN), Cigna Corporation (CI)?

Huntington Bancshares Incorporated (NASDAQ:HBAN) average daily volatility for this week is 2.38% which is less than the 3.04% recorded over the past month. Its shares dropped by -23.92% or -$3.97 from its last recorded high of $16.6 which it attained on December 03 to close at $12.63 per share. Over the past 52 weeks, the shares of Huntington Bancshares Incorporated has been trading as low as $11.12 before witnessing a massive surge by 13.58% or $1.51. This price movement has led to the HBAN stock receiving more attention and has become one to watch out for. It jumped by 0.56% on Sunday and this got the market excited. The stock’s beta now stands at 1.37 and when compared to its 200-day moving average and its 50-day moving average, HBAN price stands -14.48% below and -5.85% below respectively.

Huntington Bancshares Incorporated (HBAN) rose 2.02% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a drop that has seen it decline -18.41% and is now up by 5.96% since start of this year. A look at its monthly performance shows that the stock has recorded a -1.02% fall over the past 30 days. Its equity price dipped by -16.63% over the past three months which led to its overall six-month decrease to stand at -14.37%.

Experts from research firms are bullish about the near-term performance of Huntington Bancshares Incorporated with most of them predicting a $15.32 price target on a short-term (12 months) basis. The average price target by the analysts will see a 21.3% rise in the stock and would lead to HBAN’s market cap to surge to $16.24B. The stock has been rated an average 2.4, which roughly stands towards the bearish end of the spectrum. Reuters looked into the 22 analysts that track Huntington Bancshares Incorporated (NASDAQ:HBAN) and find out that 13 of them rated it as a Hold. 9 of the 9 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.

A look at HBAN technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 50.44 point. Its trading volume has lost -5479835 shares compared to readings over the past three months as it recently exchanged 8150165 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 13630000 shares, and this is 0.6 times the normal volume.

The price of Cigna Corporation (NYSE:CI) currently stands at $194.66 after it went up by $2.88 or 1.5% and has found a strong support at $191.2 a share. If the CI price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $187.73 mark would also be bad for the stock as it means that the stock would plunge by 3.56% from its current position. However, if the stock price is able to trade above the resistance point around $196.48, then it could likely surge higher to try and break the upward resistance which stands at $198.29 a share. Its average daily volatility over the past one month stands at 3.68%. The stock has plunged by 2.63% from its 52-weeks high of $189.55 which it reached on Jan. 29, 2018. In general, it is 16.25% above its 52-weeks lowest point which stands at $163.02 and this setback was observed on Mar. 13, 2018.

Analysts have predicted a price target for Cigna Corporation (CI) for 1 year and it stands at an average $239/share. This means that it would likely increase by 22.78% from its current position. The current price of the stock has been moving between $189.55 and $194.83. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $160. On the other hand, one analyst is super bullish about the price, setting a target as high as $304.

The CI stock Stochastic Oscillator (%D) is at 72.05%, which means that it is currently neutral. The shares P/S ratio stands at 1.63 which compares to the 0.88 recorded by the industry or the 6.26 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 11.67, which is lower than the 16.03 multiple of 12-month price-earnings (P/E). The company’s earnings have gone up, with a quarterly increase rate of 11.5% over the past five years.

Analysts view Cigna Corporation (NYSE:CI) as a Buy, with 1.9 consensus rating. Reuters surveyed 21 analysts that follow CI and found that 4 of those analysts rated the stock as a Hold. The remaining 17 were divided, with 17 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying Cigna Corporation (CI) shares or sell it if they already own it.